UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | H | J | K | L | M | O | R | S | W
Number of items: 35.


Ah-See, M-L.W.; (2007) Evaluation of the vascular response to neoadjuvant chemotherapy in primary breast cancer. Doctoral thesis, University of London. Green open access

Alonzi, R; Padhani, AR; Taylor, NJ; Stirling, JJ; Saunders, MI; Hoskin, PJ; (2007) Physiological changes within the prostate caused by androgen withdrawal. In: CLINICAL ONCOLOGY. (pp. S6 - S6).


Bajwa, A; Blunt, N; Vyas, S; McKenzie, G; Bridgewater, J; Hochhauser, D; Obichere, A; (2007) Predictive factors of outcome in patients with asymptomatic stage IV colorectal cancer and irresectable liver metastases. In: Annals of Oncology. (pp. V1170 - V1170).

Beresford, M; Lyburn, I; Sanghera, B; Makris, A; Wong, WL; (2007) Serial integrated F-18-fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma. BLACKWELL PUBLISHING


Chong, IY; Hoskin, PJ; (2007) Vaginal vault brachytherapy for low risk endometrial carcinoma. In: CLINICAL ONCOLOGY. (pp. S8 - S8).

Chong, IY; Rojas, A; Hoskin, PJ; (2007) Does a fall in lymphocyte or neutrophil count during chemoradiotherapy predict survival in cervical carcinoma? In: CLINICAL ONCOLOGY. (pp. S25 - S26).

Chowdhury, T.; (2007) Investigation of the role of MLL-ENL in leukaemogenesis. Doctoral thesis, University of London. Green open access


Dearling, JLJAPRB; (2007) Antibody directed radionuclide therapy. In: Hoskin, PJ, (ed.) Radiotherapy in Practice: Volume III Radioisotopes. (9 - 45). Oxford University Press.

Diez, P; Hoskin, PJ; (2007) Conventional and CT-based volumes in IFRT for supradiaphragmatic malignant lymphoma. In: CLINICAL ONCOLOGY. (pp. S16 - S16).


El-Emir, E; Qureshi, U; Dearling, JLJ; Boxer, GM; Clatworthy, I; Folarin, AA; ... Pedley, RB; + view all (2007) Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas. Cancer Research , 67 2639 - 2646.


Hochhauser, D; Kotecha, M; O'Hare, C; Morris, PJ; Hartley, JM; Taherbhai, Z; ... Hartley, JA; + view all (2007) Modulation of topoisomerase II expression in mammalian cells with a sequence-specific polyamide. Molecular Cancer Therapeutics , 6 (1) 346 - 354.

Hoskin, PJ; Bownes, P; Bryant, L; Ostler, P; (2007) HDR monotherapy brachytherapy for localised prostate cancer. In: CLINICAL ONCOLOGY. (pp. S7 - S7).

Hoskin, PJ; Carnell, DM; Taylor, NJ; Smith, RE; Stirling, JJ; Daley, FM; ... Padhani, AP; + view all (2007) Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY , 68 (4) 1065 - 1071.

Hoskin, PJ; Chin, Y; Wong, W; Rojas, A; (2007) The value of SUV in FDG PET for lymphoma. In: CLINICAL ONCOLOGY. (pp. S32 - S32).

Huddart, RA; O'Doherty, MJ; Padhani, A; Rustin, GJ; Mead, GM; Joffe, JK; ... Stenning, SPNCRITTCSG; + view all (2007) 18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group. Clinical Oncology , 25 (11) 1310 - 1315.


Judith, D; (2007) CT scan plan to combat cancer. Sunday Herald


Kiakos, K.; (2007) Molecular and cellular pharmacology of novel chiral and achiral CC-1065/duocarmycin analogues. Doctoral thesis, University of London. Green open access

Kogelberg, H; Sharma, SK; Qureshi, U; Tolner, B; Lowdell, M; Shabakhti, H; ... Chester, KA; + view all (2007) Clearance mechanism of a mannoseylated antibody enzyme fusion protein used in experimental cancer therapy. In: (Proceedings) NCRI Cancer Conference proceedings. (pp. 65 - ?).

Kogelberg, H; Tolner, B; Thomas, G; Di Cara, D; Ramesh, B; Sodha, S; ... Chester, K; + view all (2007) Generation of a single-chain Fv with binding specificity for the integrin, alpha v beta 6, by rational structure based antibody engineering – a promising agent for cancer therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.

Koukourakis, MI; Bentzen, SM; Giatromanolaki, A; Wilson, GD; Daley, FM; Saunders, MI; ... Harris, AL; + view all (2007) Endogenous markers of two separate hypoxia response pathways (HIF2 alpha and CA9) predict radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. Journal of Clinical Oncology , 24 (5) 727 - 735. 10.1200/jco.2005.02.7474.


Lee, SM; Woll, PJ; James, LJ; Hatton, M; Ali, K; Spiro, SG; ... Hackshaw, A; + view all (2007) A phase III randomised, double blind, placebo controlled trial of etoposide/carboplatin with or without thalidomide in advanced small cell lung cancer (SCLC). In: (Proceedings) Presidential Symposium. 12th World Conference on Lung Cancer, Seoul, Korea.. (pp. S306 - S307). Journal of Thoracic Oncology

Lee, SM; Woll, PJ; Rudd,; RM,; Gower, NH; Ottensmeier, CH; ... Hackshaw, A; + view all (2007) A phase III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC). In: (Proceedings) Proffered Paper. 12th World Conference on Lung Cancer, Seoul, Korea.. (pp. S359 - ?). Journal of Thoracic Oncology

Lowe, H; Tolner, B; Kogelberg, H; Begent, R; Robson, L; Taylorson, C; Chester, K; (2007) A novel human enzyme with a bis-chloro-phenol prodrug for Antibody Directed Enzyme Prodrug Therapy (ADEPT). In: (Proceedings) NCRI Cancer Conference Proceedings.

Lucy, M; (2007) Why I didn’t have any qualms about taking thalidomide. The Express 56 - ?.


Mandeville, HC; Ng, Q; Milner, J; Taylor, NJ; Stirling, JJ; Padhani, AR; ... Hoskin, PJ; + view all (2007) CA4P and external beam radiotherapy in prostate cancer with assessment of effect by DCE-MRI. In: CLINICAL ONCOLOGY. (pp. S38 - S38).

Marsh, D; Vigor, K; Kogelberg, H; Tolner, B; Meyer, T; Begent, R; ... Chester, K; + view all (2007) Antibody targeted magnetic nanoparticles for cancer imaging and therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.


Okkenhaug, K; Ali, K; Vanhaesebroeck, B; (2007) Antigen receptor signalling: a distinctive role for the p110 delta isoform of Pl3K. TRENDS IN IMMUNOLOGY , 28 (2) 80 - 87. 10.1016/j.it.12.007.


Ravn, P; Patel, A; Bicknell, R; Begent, RHJ; Pedley,; R, B; ... Meyer, T; + view all (2007) UNSPECIFIED In: (Proceedings) NCRI Cancer Conference Proceedings. (pp. 59 - ?).


Sainz-Pastor, N; Tolner, B; Robson, L; Parizek, P; Binz, K; Forrer, P; ... Chester, K; + view all (2007) Selection and evaluation of designed ankyrin repeat proteins (DARPins) reactive with carcinoembryonic antigen (CEA). In: (Proceedings) NCRI Cancer Conference Proceedings.

Short, SC; Martindale, C; Bourne, S; Brand, J; Johnston, P; (2007) DNA damage response in gliomas and normal human astrocytes. Neuro-Oncology , 9 (4) 404 - 411.

Short, SC; Martindale, C; Bourne, SM; Brand, G; Woodcock, M; Johnston, P; (2007) Damage signalling after TMZ and radiation in glioma cells and sensitisation by inhibition of repair in G2. In:

Sky, NRSM; (2007) Thalidomide could get cancer treatment licence. UNSPECIFIED


Wilkins, D; Mayer, A; Sharma, S; Tolner, B; Springer, C; Hartley, J; ... Begent, R; + view all (2007) Interim Results of a Phase I/II Trial of Antibody Directed Enzyme Prodrug Therapy (ADEPT) in Patients with Gastrointestinal Carcinoma. In: (Proceedings) NCRI Cancer Conference Proceedings.

Wood, K; Saunders, MI; Honess, DJ; Maxwell, RJ; Wilson, J; Paul, RL; ... Blower, PJ; + view all (2007) Evaluation of the effects of blood flow on 64Cu-ATSM distribution in a rodent tumour model. In: Radiotherapy & Oncology. (pp. S35 - S36).

Wylie, JP; Mandall, P; Bottomley, D; Hoskin, PJ; (2007) Multi-institutional UK prostate brachytherapy database. In: CLINICAL ONCOLOGY. (pp. S50 - S51).

This list was generated on Sun Jun 28 04:05:58 2015 BST.